E-Chiang Lee

E-Chiang Lee

Executive VP Research, T-Therapeutics
Verified email at t-therapeutics.com
Cited by 7590
Bispecific antibody Immunology Genetic engineering Lipid metabolism
Stephen Demarest

Stephen Demarest

Chief Scientific Officer, Tentarix Biotherapeutics
Verified email at tentarix.com
Cited by 3868
Antibody bispecific antibody auto-immunity immune-oncology
Mao Wang

Mao Wang

Regeneron Pharmaceuticals
Verified email at regeneron.com
Cited by 1232
Immunotherapy Bispecific Antibody Toxicology
Yu-Cheng Su

Yu-Cheng Su

國立交通大學生物科技學系
Verified email at nctu.edu.tw
Cited by 1224
Targeted nanomedicine Bispecific antibody Cancer therapy
Nam-Kyung Lee

Nam-Kyung Lee

Korea Research Institute of Bioscience and Biotechnology
Verified email at kribb.re.kr
Cited by 789
Antibody Engineering Bispecific Antibody Immunotherapy Cancer therapeutics Phage Display
Roberta Aliperta

Roberta Aliperta

Revitope Oncology Inc.
Verified email at revitope.com
Cited by 329
immunology immunotherapy T cells bispecific antibody
Rui Yang （杨锐）

Rui Yang （杨锐）

Wuhan YZYBIO
Verified email at yzybio.com
Cited by 248
gamma delta t cell cancer bispecific antibody PD-L1 adoptive transfer
AERIN YOON

AERIN YOON

Mogam institute for Biomedical Research
Verified email at mogam.re.kr
Cited by 216
Antibody Engineering Antibody Therapeutics Antibody Screening Bispecific Antibody
Hamid Latifi-Navid

Hamid Latifi-Navid

Ph.D. - Molecular Genetics in NIGEB
Cited by 158
bispecific antibody systems biology optogenetics cancer and age related macular degeneration
Prashant Raj Bhattarai

Prashant Raj Bhattarai

Vertex Pharmaceuticals
Verified email at vrtx.com
Cited by 72
Antibody drug conjugates antibody targeting bispecific antibody